How is the Neurocrine Biosciences, Inc. today?

The Neurocrine Biosciences, Inc. today is trading in the green, up by 1.28% at 101.38.

Neurocrine Biosciences, Inc. XNAS: NBIX

Neurocrine Biosciences, Inc. Live Share Price Today, Share Analysis and Chart

Name: Neurocrine Biosciences, Inc.: Is Infosys Ltd. worth buying?
Item: Neurocrine Biosciences, Inc.
Rating: 2.40202775
Author: Trendlyne DVM scores

Mid-range Performer

Download real time

101.38 1.28 (1.28%)

35.83% Fall from 52W High

1.9M XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Analyst Upgrade

Needham upgrades Neurocrine Bio to 'Buy'; cites positive physician survey of its drug, 'Crenessity' See details

High Financial Strength

61.1 / 100

Mid Valuation

31.0 / 100

Technically Neutral

38.9 / 100

Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

158

1Yr Price target upside is 56%

24 analysts

Neurocrine Biosciences, Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Neurocrine Biosciences, Inc. FAQ

How is Neurocrine Biosciences, Inc. today?

Neurocrine Biosciences, Inc. today is trading in the green, and is up by 1.28% at 101.38.

How has Neurocrine Biosciences, Inc. performed historically?

Neurocrine Biosciences, Inc. is currently trading up 1.28% on an intraday basis. In the past week the stock rose 11.75%. stock has been down -29.23% in the past quarter and fell -23.91% in the past year. You can view this in the overview section.